T. Rowe Price
TROW
Performance
About T. Rowe Price
T. Rowe Price is a global investment management firm dedicated to helping clients achieve long-term success. With 87 years of expert analysis, the company identifies and actively invests in opportunities to help people thrive in an evolving world.
Recent News
Sortera Is Turning America’s Scrap Aluminum Problem Into Cash
SEC Delays PENGU and T. Rowe Crypto ETFs as Grayscale Seeks Options Green Light
Inside the Agentic Operating System Code and Theory Is Teasing at CES
Intel Partners with AI Chip Startup SambaNova After Acquisition Talks Reportedly Failed
Physical Intelligence Banks $600 Million Funding
Stocks Slide on Brent Surge as Fed, BOJ Hold Rates: Markets Wrap
Active Financials ETF Holds Sector Earnings Leaders
OpenAI Secures $122 Billion Funding, Valuation Hits $852 Billion
Can US Small Caps Survive the Software Selloff?
The Private Assets Held in Public Companies
AI Credit Boom Brings New Risks for Bond Investors
3 Top Small-Cap Growth Mutual Funds for Outstanding Returns
What a Time to Run This T. Rowe Price Tech Fund
A Rare Event You Might Have Missed
Airwallex Raises $330M Series G
This Active Bond ETF Just Hit a Key Milestone as Market Vol Rises
Legal AI Giant Harvey Acquires Hexus as Competition Heats up in Legal Tech
Not All Natural Resources Stocks Win in Iran War Rally
This Name Keeps Data Centers Buzzing. Shares Set Up In A Base.
Chinese Bonds Near Inflection Point as Inflation Outlook Shifts
Waymo Raises $16B Investment Round
Nvidia-Backed SiFive Secures $400 Million, Valued at $3.65 Billion
Emirates NBD Issues World’s Largest Dual-Tranche Blue-Green Bond by a Financial Institution
Vestmark and T. Rowe Price Launch Custom Premier for RIAs
Top 3 SPAC Targets – Battery Makers
Goldman Sachs to Use Options Strategy for Planned Bitcoin Income ETF
Global Fintech Airwallex to Enable Arsenal Hospitality Payments and Improve Supporter Experience
Two Sigma, DE Shaw Join Push-Back on SEC Plan to Loosen Quarterly Reporting
U.S. Financial Regulatory Week Ahead
Airwallex Raises $330M in Series G Round at $8B Valuation
Recent Deals
Kardigan Raises $254M Series B to Advance Cardiovascular Drug Development
Kailera Therapeutics Secures $600M Series B Funding Led by Bain Capital Private Equity
Sortera Secures $45M Growth-Stage Funding Round
Physical Intelligence Secures $600M Funding Led by CapitalG
Airwallex Secures $330M Series G Funding Led by Addition
